Riverloft Capital Management’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

Riverloft Capital Management’s Portfolio APDNW Stock Details APDNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,000	Closed	-$10K	–	62
2015 Q1	$10K	Buy	+10,000	New	+$13.6K	﹤0.01%	52

Other funds holding APDNW

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Riverloft Capital Management's APDNW Position: Q2 2015 in Review

Riverloft Capital Management sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q2 2015, closing a stake of 10,000 shares — an estimated $10K sold.

Riverloft Capital Management first reported a position in APDNW in Q1 2015 and held it in 1 quarter. The position peaked at $10K in Q1 2015. 7 funds tracked by Wall St. Rank hold APDNW as of Q2 2015.

Riverloft Capital Management reported no remaining Applied DNA Sciences Inc Warrant position as of Q2 2015 after selling out during the quarter.
Riverloft Capital Management sold 10,000 Applied DNA Sciences Inc Warrant shares in Q2 2015, an estimated $10K.
Riverloft Capital Management first reported a position in Applied DNA Sciences Inc Warrant in Q1 2015 and held it in 1 quarter.
Riverloft Capital Management's Applied DNA Sciences Inc Warrant position peaked at $10K in Q1 2015.
7 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q2 2015.

Based on Riverloft Capital Management's 13F filing for Q2 2015, filed 10 Aug 2015.